Logo
Bg pattern

MEBEVERINE TARBIS 135 mg FILM-COATED TABLETS

Prescription review online

Prescription review online

A doctor will review your case and decide whether a prescription is medically appropriate.

Talk to a doctor about this medicine

Talk to a doctor about this medicine

Discuss your symptoms and possible next steps in a quick online consultation.
This page is for general information. Consult a doctor for personal advice. Call emergency services if symptoms are severe.
About the medicine

How to use MEBEVERINE TARBIS 135 mg FILM-COATED TABLETS

Translated with AI

This page provides general information and does not replace a doctor’s consultation. Always consult a doctor before taking any medication. Seek urgent medical care if symptoms are severe.

Show original

Contents of the leaflet

  1. Introduction
  2. What Mebeverina Tarbis is and what it is used for
  3. What you need to know before you take Mebeverina Tarbis
  4. How to take Mebeverina Tarbis
  5. Possible side effects
  6. Storage of Mebeverina Tarbis
  7. Contents of the pack and other information

Introduction

Patient Information: Summary of Product Characteristics

Mebeverina Tarbis 135 mg film-coated tablets EFG

mebeverine hydrochloride

Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.

  • Keep this leaflet, you may need to read it again.
  • If you have any further questions, ask your doctor or pharmacist.
  • This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours.
  • If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4.

Contents of the pack

  1. What Mebeverina Tarbis is and what it is used for
  2. What you need to know before you take Mebeverina Tarbis
  3. How to take Mebeverina Tarbis
  4. Possible side effects
  5. Storage of Mebeverina Tarbis
  6. Contents of the pack and other information

1. What Mebeverina Tarbis is and what it is used for

Mebeverina 135 mg film-coated tablets contain the active substance mebeverine hydrochloride, which belongs to a group of medicines called antispasmodics, which act on the intestine.

This medicine is used to relieve the symptoms of irritable bowel syndrome (IBS) and other similar conditions such as irritable colon in adults.

Irritable bowel syndrome (IBS) is a very common condition that causes spasms and pain in the intestine.

The intestine is a long muscular tube through which food passes to be digested. If a spasm occurs in the intestine and the pressure is too strong, it causes pain.

The symptoms vary from person to person, but may include:

  • stomach pain and colic
  • feeling of abdominal distension and gas
  • diarrhea, constipation, or a combination of both

small, hard, fragmented, or pellet-like stools

Your diet and lifestyle can also help treat irritable bowel syndrome (IBS):

A high-fiber diet may be helpful, but consult your doctor or pharmacist for more information.

Relaxation can help reduce IBS symptoms.

Doctor consultation

Not sure if this medicine is right for you?

Discuss your symptoms and treatment with a doctor online.

2. What you need to know before you take Mebeverina Tarbis

Do not take Mebeverina

  • If you are allergic to mebeverine hydrochloride or any of the other ingredients of this medicine (listed in section 6).

If you have intestinal obstruction (paralytic ileus)

Warnings and precautions

Consult your doctor or pharmacist before starting to take this medicine.

If you develop new symptoms or if your symptoms worsen

Other medicines and Mebeverina Tarbis

Tell your doctor or pharmacist if you are taking, have recently taken, or might take any other medicines.

Pregnancy and breastfeeding

If you are pregnant or breastfeeding, think you may be pregnant, or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine.

Mebeverine is not recommended during pregnancy or breastfeeding.

Driving and using machines

This medicine is unlikely to affect your ability to drive or use tools or machines.

Mebeverina Tarbis contains lactose

Each film-coated tablet contains 97 mg of lactose (as lactose monohydrate).

If your doctor has told you that you have an intolerance to some sugars, consult them before taking this medicine.

Mebeverina Tarbis contains sodium

This medicine contains less than 1 mmol of sodium (23 mg) per tablet; this is essentially "sodium-free".

3. How to take Mebeverina Tarbis

Follow exactly the administration instructions of this medicine given by your doctor or pharmacist. If you are in doubt, consult your doctor or pharmacist again.

Medicine questions

Started taking the medicine and have questions?

Discuss your symptoms and treatment with a doctor online.

Taking this medicine

  • Mebeverine is indicated in adults
  • Take the tablet whole, without dividing it into smaller pieces or chewing it, with a full glass of water, approximately 20 minutes before meals.
  • Try to take your tablets at the same time each day. This will help you remember when to take them.

Use in adults

The recommended dose is one tablet (135 mg of mebeverine hydrochloride) 3 times a day. Do not take more than 3 tablets per day and space the doses evenly throughout the day.

Use in children and adolescents

This medicine is not recommended for use in children and adolescents under 18 years, as there are not enough data available.

If you take more Mebeverina Tarbis than you should

If you have taken more mebeverine than you should or have accidentally ingested the contents of the pack, consult your doctor or pharmacist immediately or contact the Toxicology Information Service, telephone: 91 562 04 20, indicating the medicine and the amount ingested. It is recommended to take the pack and the leaflet of the medicine to the healthcare professional.

If you forget to take Mebeverina Tarbis

Do not take a double dose to make up for forgotten doses.

If you stop taking Mebeverina Tarbis

Do not stop taking this medicine without consulting your doctor, even if you feel better.

If you have any other questions about the use of this medicine, ask your doctor or pharmacist.

4. Possible side effects

Like all medicines, this medicine can cause side effects, although not everybody gets them.

Stop taking this medicine and consult a doctor immediately if you experience any of the following serious side effects, as you may need urgent medical treatment:

  • Difficulty breathing, swelling of the face, neck, lips, tongue, or throat. You may be experiencing a severe allergic reaction (hypersensitivity) to this medicine.

Other side effects are:

  • You may experience a milder allergic reaction (hypersensitivity) to the medicine: for example, skin rash, redness, and itching.
  • Very rare cases of dizziness, drowsiness, confusion, and nausea have been reported.

Reporting of side effects

If you experience any side effects, talk to your doctor, pharmacist, or nurse. This includes any possible side effects not listed in this leaflet. You can also report side effects directly through the Spanish Medicines and Healthcare Products Agency (AEMPS) website: www.notificaRAM.es. By reporting side effects, you can help provide more information on the safety of this medicine.

5. Storage of Mebeverina Tarbis

Keep this medicine out of the sight and reach of children.

This medicine does not require any special storage conditions.

Do not use this medicine after the expiry date which is stated on the pack after "EXP". The expiry date is the last day of the month shown.

Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. These measures will help protect the environment.

6. Contents of the pack and other information

Composition of Mebeverina Tarbis

The active substance is mebeverine hydrochloride.

Each film-coated tablet contains 135 mg of mebeverine hydrochloride.

The other excipients are:

Core of the tablet: lactose monohydrate, microcrystalline cellulose, sodium starch glycolate (type A, potato), povidone, talc, magnesium stearate

Coating of the tablet: hypromellose, macrogol, titanium dioxide

Appearance of the product and contents of the pack

White, round, biconvex, and smooth film-coated tablets on both sides.

Diameter: 10.0 mm and thickness: 4.3 mm

Mebeverina Tarbis 135 mg film-coated tablets EFG are available in Al/PVC and PVC/PVDC-aluminum blisters in packs of 60 tablets.

Marketing authorization holder

Tarbis Farma S.L.

Gran Vía Carlos III, 94

08028 Barcelona

Spain

Manufacturer

Amarox Pharma B.V

Rouboslaan 32, Voorschoten,

2252TR Netherlands

Or

Meiji Pharma Spain S.A.

Avda. de Madrid 94 – Alcalá de Henares

28802 – Spain

Date of last revision of this leaflet: May 2025

Detailed and up-to-date information on this medicine is available on the website of the Spanish Agency for Medicines and Healthcare Products (AEMPS) http://www.aemps.gob.es/

Online doctors for MEBEVERINE TARBIS 135 mg FILM-COATED TABLETS

Discuss questions about MEBEVERINE TARBIS 135 mg FILM-COATED TABLETS, including use, safety considerations and prescription review, subject to medical assessment and local regulations.

0.0 (1)
Doctor

Maryna Kuznetsova

Cardiology 17 years exp.

Dr Marina Kuznetsova is an internal medicine doctor and cardiologist with a PhD in medicine. She provides online consultations for adults with chronic and acute conditions, with a strong focus on cardiovascular health. Her approach is based on current clinical guidelines and evidence-based treatment strategies.

Areas of expertise:

  • dyslipidaemia and lipid metabolism disorders
  • prevention and management of atherosclerosis
  • blood pressure monitoring and antihypertensive therapy
  • arrhythmias: diagnosis, follow-up, and treatment adjustment
  • cardiovascular care and recovery support after Covid-19
Dr Kuznetsova helps patients manage cardiovascular risk factors, optimise long-term treatment, and gain clarity in complex health situations – all through accessible and structured online care.
Camera Book a video appointment
€60
0.0 (0)
Doctor

Tetiana Fedoryshyn

General medicine 30 years exp.

Dr Tetiana Fedoryshyn is a senior general practitioner, certified nutritionist, and psychologist with over 29 years of clinical experience. She combines classical internal medicine with modern approaches in lifestyle medicine, functional nutrition, and emotional health support. Her focus is on helping patients regain health through deep understanding of symptoms, personalised nutrition plans, and evidence-based correction of deficiencies, stress-related conditions, and metabolic imbalances. Dr Fedoryshyn works with adults experiencing chronic conditions, fatigue, hormonal disruption, and post-stress exhaustion. She integrates medical analysis, psychological insight, and real-life behaviour change tools to offer treatment plans tailored to each patient’s biochemistry, mental state, and lifestyle. Main areas of practice: 

  • Chronic condition management and medical counselling
  • Weight loss programmes based on metabolic profiling
  • Diagnosis and treatment of micronutrient deficiencies
  • Recovery from stress, burnout, and hormonal imbalances
  • Emotional support and psychosomatic symptom care

Her approach is never one-size-fits-all – each consultation begins with a deep dive into your unique health history, test results, and emotional landscape. Consultations are available in Ukrainian, Polish, and Russian.
Camera Book a video appointment
€0
0.0 (18)
Doctor

Muhammad Tayyab Altaf

General medicine 3 years exp.

Dr. Muhammad Tayyab Altaf is a primary care physician with extensive international experience, offering online consultations for adults and children. His background includes clinical practice in Policlinico San Matteo Hospital Pavia in Italy, Mount Sinai Hospital in New York, United States and other healthcare settings, allowing him to manage a wide range of acute and chronic medical conditions with confidence and clarity.

His clinical expertise spans multi-system conditions, preventive care and long-term management of chronic diseases. Dr. Altaf combines hands-on experience with a strong research background in both medical and surgical fields, enabling him to provide accurate assessments and structured, evidence-based treatment plans. Patients value his ability to explain diagnoses clearly, outline next steps and support them in making informed healthcare decisions.

Online consultations with Dr. Altaf are suitable for many everyday and acute situations where a timely medical opinion can help determine the safest next steps. He evaluates and treats conditions affecting the cardiovascular, respiratory, gastrointestinal, neurological, haematological and endocrine systems. Common examples include:

  • hypertension and other blood pressure issues
  • ischaemic heart disease and angina
  • asthma, COPD and emphysema
  • pneumonia and lung fibrosis
  • gastroenteritis and digestive infections
  • liver conditions, including alcohol-related disease
  • epilepsy, seizures and post-stroke symptoms
  • dementia and cognitive decline
  • anaemia and other haematological changes
  • diabetes, thyroid disorders and pituitary disease
Many patients reach out when they experience new or worsening symptoms, fluctuations in blood pressure, non-severe chest discomfort, breathing symptoms, digestive issues, suspected infections, chronic fatigue or concerns that affect daily life. He also helps patients understand test results, adjust existing treatment plans and navigate long-term health strategies safely and effectively.

When clinically appropriate, Dr. Altaf can also provide health and fitness certificates, including documentation required for physical activity, sports participation or gym use, based on the patient’s health status and medical indications.

Some conditions are not suitable for online care. Severe chest pain, loss of consciousness, uncontrolled bleeding, seizures, major trauma or symptoms suggesting a stroke or heart attack require immediate attention from local emergency services. Dr. Altaf prioritises patient safety and will guide you accordingly if your situation needs urgent in-person care.

In all consultations, Dr. Muhammad Tayyab Altaf focuses on clear communication, accurate diagnosis and patient-centred decision-making. His approach ensures that individuals and families feel informed, supported and confident in their next steps, no matter where they are.
Camera Book a video appointment
€50
4

Frequently Asked Questions

Is a prescription required for MEBEVERINE TARBIS 135 mg FILM-COATED TABLETS?
MEBEVERINE TARBIS 135 mg FILM-COATED TABLETS requires a prescription in Spain. You can check with a doctor online whether this medicine may be appropriate for your situation.
What is the active substance in MEBEVERINE TARBIS 135 mg FILM-COATED TABLETS?
The active ingredient in MEBEVERINE TARBIS 135 mg FILM-COATED TABLETS is mebeverine. This information helps identify medicines with the same composition but different brand names.
Who manufactures MEBEVERINE TARBIS 135 mg FILM-COATED TABLETS?
MEBEVERINE TARBIS 135 mg FILM-COATED TABLETS is manufactured by Tarbis Farma S.L.. Pharmacy brands and packaging may differ depending on the distributor.
Which doctors can assess the use of MEBEVERINE TARBIS 135 mg FILM-COATED TABLETS online?
Doctors such as Family doctors, Psychiatrists, Dermatologists, Cardiologists, Endocrinologists, Gastroenterologists, Pulmonologists, Nephrologists, Rheumatologists, Hematologists, Infectious disease physicians, Allergists, Geriatricians, Paediatricians, Oncologists may assess whether MEBEVERINE TARBIS 135 mg FILM-COATED TABLETS is appropriate, depending on your situation and local regulations. You can book an online consultation to discuss your symptoms and possible next steps.
What are the alternatives to MEBEVERINE TARBIS 135 mg FILM-COATED TABLETS?
Other medicines with the same active substance (mebeverine) include DUSPATALIN 135 mg FILM-COATED TABLETS, AERO RED 40 mg CHEWABLE TABLETS, AERO-RED 120 mg CHEWABLE TABLETS. These may have different brand names or formulations but contain the same therapeutic ingredient. Always consult a doctor before switching or starting a new medicine.
bg-pattern-dark

Stay informed about Oladoctor

News about new services, product updates and useful information for patients.

Follow us on social media